Code | 3202E | ||||||||||
MA number | EU/1/22/1713/002 | ||||||||||
Product Form: | con inf 1x15 ml/300 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | AstraZeneca AB, Sweden | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 20.02.2023 |
Validity: | 20.02.2028 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 03.03.2023 |